6:44 PM
Nov 12, 2015
 |  BC Extra  |  Company News

WuXi NextCODE gets 100,000 Genomes contract

The WuXi NextCODE subsidiary of WuXi PharmaTech Inc. (NYSE:WX) entered a contract with Genomics England Ltd. (London, U.K.) to interpret genomic data from patients participating in the U.K.'s 100,000 Genomes Project. The project aims to sequence and study the genomes of 100,000 NHS England patients by 2017, with a focus on rare diseases...

Read the full 255 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >